Search Dental Tribune

Corus boosts growth in France with appointment of Nicolas Bonnard as CEO


The latest news in dentistry free of charge.

  • This field is for validation purposes and should be left unchanged.
Nicolas Bonnard (left) has been named the new CEO of prosthetics and orthodontics company Corus, taking over from current CEO and company founder Juan Roma (right). (Image: Corus)
Dental Tribune International

By Dental Tribune International

Thu. 27. January 2022


PARIS, France: The French dental market is on its way to becoming the key market for prosthetics and orthodontics company Corus. The company serves over 2,400 dentists in France with its 14 laboratories and 300 staff members and has now increased its commitment to dentists in the country with the appointment of Nicolas Bonnard—currently head of French operations—as its new CEO.

Bonnard will take up the position of CEO from 1 March. “It is a great honour to take on the challenge of directing and continuing to develop the Corus project with our partners, the directors of the laboratories that make up the group, and an excellent team of professionals,” Bonnard commented in a press bulletin.

“Our company is driving the paradigm shift in the new dentistry: digital, personalised and high added value for the dentist and for the patient,” Bonnard said. He explained, “The European dental prosthesis market is undergoing a process of consolidation and profound change thanks to digitalisation. Corus’ goal is to lead this transformation in the coming years through the integration of leading laboratories and to capitalise on the group’s innovation capacity.”

Bonnard will take over from current CEO Juan Roma, who founded the company. Roma will become executive president of the group and will remain a partner at the private equity firm Careventures, which is Corus’ main shareholder and investor. Roma commented: “We are committed to Corus’ European development. The confidence and talent of Nicolas Bonnard and the results obtained by him over the last few years, in conjunction with his multidisciplinary experience and Corus’ great management team, are the best guarantees of continuing successful growth.”

“Our company is driving the paradigm shift in the new dentistry: digital, personalised and high added value for the dentist and for the patient” – Nicolas Bonnard, Corus

As country manager, Bonnard has overseen the growth of Corus in France. A strategic cornerstone for the group, France is currently Corus’ second-largest market by turnover and is set to become its leading market in 2022, when revenues are expected to exceed €40 million. The company began its French operations in 2016, and since then it has registered an organic annual growth close to 10%. Last year, its revenue in the country was €32 million, and approximately 180,000 dental patients were treated in France using its products.

Bonnard is an engineering graduate of the École Nationale Supérieure d'Arts et Métiers in Paris and holds a master’s degree in entrepreneurship from HEC Paris. He joined Corus in 2017 as corporate development manager for the French market, and in 2018 he made the leap to country manager. He is also a member of Corus’ executive committee and strategy committee.

Corus—a story of success

Founded in 2015, Corus has emerged as a leader in the market for cutting-edge dental prostheses that accompany dentists in the transformation to digital dentistry. Having innovative and unique products and services that are based on digitalisation and aesthetics, the company has a holistic vision and is focused on the patient experience.

In addition to its operations in France, Corus is present in Spain, where it has 15 laboratories, and in Portugal, where it has four laboratories. Last year, the company posted revenues of €73 million—a year-over-year increase of 38%—and in the future, it plans to enter new European markets.

Corus is immersed in the paradigm shift towards a new dentistry: 100% digitised, personalised and with added value for the patient. Through its Corus Link cloud platform, dentists can interact with the laboratory and the patient, guaranteeing the traceability of both the prescription and the information necessary to tailor the products and services to the patient. The laboratories advise the dentist on the best prescription decisions, digitally designing the rehabilitation by using their own CAD software tools and producing, with state-of-the-art 3D-printing centres, unique products that are customised for the individual morphology and needs of the patient.

Leave a Reply

Your email address will not be published. Required fields are marked *